When is a double better Than a TRIPLE?: Stenting in patients with atrial fibrillation

Journal of the American College of Cardiology

Volumn 65, Issue 16, 2015, Pages 1630-1632

  Bhatt, Deepak L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

anticoagulants; aspirin; percutaneous coronary intervention; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; CLOPIDOGREL; DABIGATRAN; RIVAROXABAN; WARFARIN; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CORONARY STENTING; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG ELUTING STENT; DRUG INDICATION; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; STENT THROMBOSIS; TREATMENT DURATION; ANALOGS AND DERIVATIVES; FEMALE; MALE;

ASPIRIN; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 84928017955     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.02.051     Document Type: Editorial

References (12)

1. D.L. Bhatt, J.S. Hulot, and D.J. Moliterno et al. Antiplatelet and anticoagulation therapy for acute coronary syndromes Circ Res 114 2014 1929 1943
2. V. Fuster, L.E. Ryden, and D.S. Cannom et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
3. J.L. Anderson, J.L. Halperin, and N.M. Albert et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 1935 1944
4. D.L. Bhatt, M.E. Bertrand, and P.B. Berger et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting J Am Coll Cardiol 39 2002 9 14
5. M. Vardi, M. Debidda, and D.L. Bhatt et al. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists Clin Cardiol 37 2014 103 107
6. W.J. Dewilde, T. Oirbans, and F.W. Verheugt et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
7. G.Y. Lip, S. Windecker, and K. Huber et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) Eur Heart J 35 2014 3155 3179
8. K.A. Fiedler, M. Maeng, and J. Mehilli et al. Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial J Am Coll Cardiol 65 2015 1619 1629
9. R. Mehran, S.V. Rao, and D.L. Bhatt et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
10. D.P. Faxon, J.W. Eikelboom, and P.B. Berger et al. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective Thromb Haemost 106 2011 572 584
11. N.S. Abraham, M.A. Hlatky, and E.M. Antman et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 56 2010 2051 2066
12. C.T. Ruff, R.P. Giugliano, and E. Braunwald et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 383 2014 955 962